The MAPK/Erk signaling pathway is central in T-ALL and it has been recently shown to drive steroid resistance by phosphorylation and inactivation of the pro-apoptotic BH3-only protein BIM [12]. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.